| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |